Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 28, 2017; 23(44): 7888-7898
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7888
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7888
Parameter | A-CD patients (n = 29) | R-CD patients (n = 37) | HCs (n = 37) | P |
Age (yr) | 31.38 ± 9.51 | 31.97 ± 8.86 | 31.41 ± 5.69 | 0.941a |
Gender (female/male) | 17/12 | 20/17 | 18/19 | 0.719a |
CRP (mg/L) | 45.96 (32.27-67.26) | 18.94 (10.78-26.71) | 3.99 (3.33-6.06) | < 0.001a |
ESR (mm/H) | 43.93 (37.46-57.82) | 16.73 (11.36-20.40) | 13.02 (5.82-15.27) | < 0.001a |
CDAI score | 206.0 (170.5-253.0) | 95.0 (75.5-112.0) | - | < 0.001c |
IL-17 (pg/mL) | 46.90 (38.46-60.06) | 18.07 (10.21-20.17) | - | < 0.001c |
TNF-α (pg/mL) | 72.77 (53.46-83.39) | 22.17 (19.49-30.43) | - | < 0.001c |
INF-γ (pg/mL) | 33.23 (24.59-39.54) | 11.62 (9.16-15.07) | - | < 0.001c |
- Citation: Sun CM, Wu J, Zhang H, Shi G, Chen ZT. Circulating miR-125a but not miR-125b is decreased in active disease status and negatively correlates with disease severity as well as inflammatory cytokines in patients with Crohn’s disease. World J Gastroenterol 2017; 23(44): 7888-7898
- URL: https://www.wjgnet.com/1007-9327/full/v23/i44/7888.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i44.7888